|
Originally published In Press as doi:10.1074/jbc.M304528200 on November 1, 2003
J. Biol. Chem., Vol. 279, Issue 7, 5915-5923, February 13, 2004
MARK4 Is a Novel Microtubule-associated Proteins/Microtubule Affinity-regulating Kinase That Binds to the Cellular Microtubule Network and to Centrosomes*
Bernhard Trinczek ,
Miro Brajenovic ¶,
Andreas Ebneth||, and
Gerard Drewes¶**
From the
Department of Medicinal Chemistry, University of Kansas, Malott Hall, Lawrence, Kansas 66045, ¶Cellzome AG, Meyerhofstrasse 1, D-69117 Heidelberg, Germany, and ||EVOTEC NeuroSciences GmbH, Schnackenburgallee 114, 22525 Hamburg, Germany
The MARK protein kinases were originally identified by their ability to phosphorylate a serine motif in the microtubule-binding domain of tau that is critical for microtubule binding. Here, we report the cloning and expression of a novel human paralog, MARK4, which shares 75% overall homology with MARK1-3 and is predominantly expressed in brain. Homology is most pronounced in the catalytic domain (90%), and MARK4 readily phosphorylates tau and the related microtubule-associated protein 2 (MAP2) and MAP4. In contrast to the three paralogs that all exhibit uniform cytoplasmic localization, MARK4 colocalizes with the centrosome and with microtubules in cultured cells. Overexpression of MARK4 causes thinning out of the microtubule network, concomitant with a reorganization of microtubules into bundles. In line with these findings, we show that a tandem affinity-purified MARK4 protein complex contains -, -, and -tubulin. In differentiated neuroblastoma cells, MARK4 is localized prominently at the tips of neurite-like processes. We suggest that although the four MARK/PAR-1 kinases might play multiple cellular roles in concert with different targets, MARK4 is likely to be directly involved in microtubule organization in neuronal cells and may contribute to the pathological phosphorylation of tau in Alzheimer's disease.
Received for publication, April 30, 2003
, and in revised form, September 12, 2003.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AY057448 and AF465413.
This work contains part of the doctoral thesis of M. B. at the University of Heidelberg.
* This work was supported in part by the Max-Planck Gesellschaft and the Human Frontier Science Program. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
** To whom correspondence should be addressed: Cellzome AG, Meyerhofstrasse 1, D-69117 Heidelberg, Germany. Tel.: 49-6221-13757350; Fax: 49-6221-13757206; E-mail: Gerard.Drewes{at}Cellzome.com.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Cicchillitti, R. Penci, M. Di Michele, F. Filippetti, D. Rotilio, M. B. Donati, G. Scambia, and C. Ferlini
Proteomic characterization of cytoskeletal and mitochondrial class III {beta}-tubulin
Mol. Cancer Ther.,
July 1, 2008;
7(7):
2070 - 2079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Hurov, M. Huang, L. S. White, J. Lennerz, C. S. Choi, Y.-R. Cho, H.-J. Kim, J. L. Prior, D. Piwnica-Worms, L. C. Cantley, et al.
Loss of the Par-1b/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo
PNAS,
March 27, 2007;
104(13):
5680 - 5685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ichihara-Tanaka, A. Oohira, M. Rumsby, and T. Muramatsu
Neuroglycan C Is a Novel Midkine Receptor Involved in Process Elongation of Oligodendroglial Precursor-like Cells
J. Biol. Chem.,
October 13, 2006;
281(41):
30857 - 30864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Dequiedt, M. Martin, J. Von Blume, D. Vertommen, E. Lecomte, N. Mari, M.-F. Heinen, M. Bachmann, J.-C. Twizere, M. C. Huang, et al.
New Role for hPar-1 Kinases EMK and C-TAK1 in Regulating Localization and Activity of Class IIa Histone Deacetylases.
Mol. Cell. Biol.,
October 1, 2006;
26(19):
7086 - 7102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Goransson, M. Deak, S. Wullschleger, N. A. Morrice, A. R. Prescott, and D. R. Alessi
Regulation of the polarity kinases PAR-1/MARK by 14-3-3 interaction and phosphorylation
J. Cell Sci.,
October 1, 2006;
119(19):
4059 - 4070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fourest-Lieuvin, L. Peris, V. Gache, I. Garcia-Saez, C. Juillan-Binard, V. Lantez, and D. Job
Microtubule Regulation in Mitosis: Tubulin Phosphorylation by the Cyclin-dependent Kinase Cdk1
Mol. Biol. Cell,
March 1, 2006;
17(3):
1041 - 1050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A Moore and M. Zernicka-Goetz
PAR-1 and the microtubule-associated proteins CLASP2 and dynactin-p50 have specific localisation on mouse meiotic and first mitotic spindles
Reproduction,
September 1, 2005;
130(3):
311 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Matenia, B. Griesshaber, X.-y. Li, A. Thiessen, C. Johne, J. Jiao, E. Mandelkow, and E.-M. Mandelkow
PAK5 Kinase Is an Inhibitor of MARK/Par-1, Which Leads to Stable Microtubules and Dynamic Actin
Mol. Biol. Cell,
September 1, 2005;
16(9):
4410 - 4422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sakamoto, O. Goransson, D. G. Hardie, and D. R. Alessi
Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR
Am J Physiol Endocrinol Metab,
August 1, 2004;
287(2):
E310 - E317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Brajenovic, G. Joberty, B. Kuster, T. Bouwmeester, and G. Drewes
Comprehensive Proteomic Analysis of Human Par Protein Complexes Reveals an Interconnected Protein Network
J. Biol. Chem.,
March 26, 2004;
279(13):
12804 - 12811.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|